期刊文献+

孕激素受体A型原核表达及单克隆抗体制备

Expression of progesterone receptor a protein in prokaryotic and preparation of monoclonal antibodies to PR-A
下载PDF
导出
摘要 目的:制备孕激素受体A型单克隆抗体,为后期应用到免疫组化实验提供支持。方法:选择无缝克隆的方法将目的基因与载体连接到一起,通过诱导表达收集蛋白,经过免疫后细胞融合获得单克隆抗体。将该单克隆抗体经免疫组化验证。结果:将融合后筛选的阳性细胞制备获得的单克隆抗体7C7经免疫组化验证,发现其在乳腺癌、子宫肌瘤组织中呈现阳性,在直肠癌组织、平滑肌组织中呈现阴性,符合目的抗体的要求。结论:该方法获得的孕激素受体A型单克隆抗体较常规方法周期短,获得的抗体在不同组织间结果符合预判,对后期研究区别PR-A、PR-B,临床推广具有重要意义。 Objective: To prepare for m Ab of progesterone receptor. It would provide support for the immunohistochemistry behind. Methods: Target gene connected together with a carrier by seamless cloning method. The target protein that expression by inducing was collected. And with cell fusion method,the monoclonal antibodies were preparation. Then the m Ab were detected by IHC. Results: The m Ab( clone 7C7) was detected and it found positive for the breast,uterine fibroid tissue,showed negative in colorectal cancer tissue,smooth muscle tissue,the goal of the claim were achieve. Conclusion: Finally,we found the method that prepare for m Ab was far beyond our imagination. The result of IHC on different samples about m Ab( 7C7) obtained compliance with anticipation. Study on the difference between the PR-A and PR-B had significance.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2016年第7期1013-1016,共4页 Chinese Journal of Immunology
关键词 孕激素受体 原核表达 单克隆抗体 Progesterone receptor Prokaryotic expression Monoclonal antibody
  • 相关文献

参考文献5

二级参考文献23

  • 1宋三泰,孔繁华.乳腺癌及其ER状态与HLA关联的研究[J].中华肿瘤杂志,1989,11(1):19-21. 被引量:1
  • 2杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:278
  • 3Vitale M, Rezzani R, Rodella Let al. HLA class I antigen and transporter associated with antigen processing (TAP1 and TAV2) down-regulation in high-grade primary breast carcinoma lesions [ J]. Cancer Res, 1998; 58 (4) :737-742.
  • 4Chaudhuri S, Cariappa A, Tang M et al. Genetic susceptibility to breast cancer: HLA DQB * 03032 and HLA DRBI * 11 may represent protective alleles[J]. Proc Natl Aead Sci USA,2000; 97(21 ) : 11451-11454.
  • 5de Jong M M, Nohe I M, de Vries E Get al. The HLA class Ⅲ subregion is responsible for an increased breast cancer risk [J]. Human Mol Genet, 2003 ; 12(18) : 2311-2319.
  • 6Sommer S and Fuqua S A. Estrogen receptor and breast cancer [J]. Semin Cancer Biol, 2001 ; 11 (5) : 339-352.
  • 7Gourley C, Thornton C, Massie C et al. Is there a relationship between HLA type and prognostic factors in breast cancer? [J]. Anticancer Res, 2003 ; 23 ( 1 B) : 633-638.
  • 8Gun FD, Ozturk O G, Polat A et al. HLA class-Ⅱ allele frequencies in Turkish breast cancer patients [J]. Med Oncol, 2011; doi: 10. 1007/ s12032-011-9873-4.
  • 9Jemal A, Bray F, Center M Met al. Global cancer statistics[ J ]. CA Cancer J Clin,2011 ;61 (2) :69-90.
  • 10Petrone A, Bugawan T L, Mesturino C Aet al. The distribution of HLA class Ⅱ susceptible/protective haplotypes could partially explain the low incidence of type 1 diabetes in continental Italy (Lazio region) [J]. Tissue Antigens, 2001 ; 58 (6) : 385-394.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部